Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2015, Article ID 373762, 8 pages
http://dx.doi.org/10.1155/2015/373762
Research Article

Dysglycaemia and Other Predictors for Progression or Regression from Impaired Fasting Glucose to Diabetes or Normoglycaemia

1School of Medicine, Deakin University, 285 Ryrie Street, Geelong, VIC 3220, Australia
2Department of Medicine, NorthWest Academic Centre, The University of Melbourne, 176 Furlong Road, St Albans, VIC 3021, Australia
3Barwon Health, Ryrie Street, Geelong, VIC 3220, Australia

Received 28 April 2015; Revised 10 June 2015; Accepted 7 July 2015

Academic Editor: Christoph H. Saely

Copyright © 2015 L. de Abreu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. D. Mathers and D. Loncar, “Projections of global mortality and burden of disease from 2002 to 2030,” PLoS Medicine, vol. 3, no. 11, article e442, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Danaei, M. M. Finucane, Y. Lu et al., “National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants,” The Lancet, vol. 378, no. 9785, pp. 31–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. Diabetes Australia, Diabetes Australia Welcomes Coalition Health Policy Focus on a Better Response to the Rising Diabetes Epidemic, Diabetes Australia, 2013.
  4. S. Genuth, K. G. M. M. Alberti, P. Bennett et al., “Follow-up report on the diagnosis of diabetes mellitus,” Diabetes Care, vol. 26, no. 11, pp. 3160–3167, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. K.-T. Chen, C.-J. Chen, E. W. Gregg, G. Imperatore, and K. M. V. Narayan, “Impaired fasting glucose and risk of diabetes in Taiwan: follow-up over 3 years,” Diabetes Research and Clinical Practice, vol. 60, no. 3, pp. 177–182, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. M. Gabir, R. L. Hanson, D. Dabelea et al., “The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes,” Diabetes Care, vol. 23, no. 8, pp. 1108–1112, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. O. R. Pour and S. Dagogo-Jack, “Prediabetes as a therapeutic target,” Clinical Chemistry, vol. 57, no. 2, pp. 215–220, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. N. G. Forouhi, J. Luan, S. Hennings, and N. J. Wareham, “Incidence of Type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990–2000,” Diabetic Medicine, vol. 24, no. 2, pp. 200–207, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. D. J. Magliano, E. L. M. Barr, P. Z. Zimmet et al., “Glucose indices, health behaviors, and incidence of diabetes in Australia: the Australian diabetes, obesity and lifestyle study,” Diabetes Care, vol. 31, no. 2, pp. 267–272, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Zimmet, “Diabesity in Australia: an affair of the heart,” Heart Lung and Circulation, vol. 12, supplement 2, pp. S95–S98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Bonora, S. Kiechl, J. Willeit et al., “Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study,” Diabetes, vol. 53, no. 7, pp. 1782–1789, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Heianza, K. Kato, S. Kodama et al., “Risk of the development of Type 2 diabetes in relation to overall obesity, abdominal obesity and the clustering of metabolic abnormalities in Japanese individuals: does metabolically healthy overweight really exist? The Niigata Wellness Study,” Diabetic Medicine, vol. 32, no. 5, pp. 665–672, 2015. View at Publisher · View at Google Scholar
  13. P. Zimmet, “Diabesity in Australia: an affair of the heart,” Heart Lung and Circulation, vol. 12, pp. S95–S98, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. J. A. Pasco, G. C. Nicholson, and M. A. Kotowicz, “Cohort profile: geelong osteoporosis study,” International Journal of Epidemiology, vol. 41, no. 6, Article ID dyr148, pp. 1565–1575, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. NHMRC, Clinical Practice Guidelines for the Management of Overweight and Obesity in Adults, Adolescents and Children in Australia, NHMRC, 2013.
  16. S. K. Tanamas, D. J. Magliano, B. Lynch et al., AusDiab 2012. The Australian Diabetes, Obesity and Lifestyle Study, Baker IDI Heart and Diabetes Institute, Melbourne, Australia, 2013.
  17. R. Huxley, S. Mendis, E. Zheleznyakov, S. Reddy, and J. Chan, “Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk—a review of the literature,” European Journal of Clinical Nutrition, vol. 64, no. 1, pp. 16–22, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. L. M. Browning, S. D. Hsieh, and M. Ashwell, “A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0.5 could be a suitable global boundary value,” Nutrition Research Reviews, vol. 23, no. 2, pp. 247–269, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. S. L. Brennan, M. J. Henry, G. C. Nicholson, M. A. Kotowicz, and J. A. Pasco, “Socioeconomic status and risk factors for obesity and metabolic disorders in a population-based sample of adult females,” Preventive Medicine, vol. 49, no. 2-3, pp. 165–171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Kunst, B. Draeger, and J. Ziegenhorn, “UV-methods with hexokinase and glucose-6-phosphate dehydrogenase,” in Methods of Enzymatic Analysis, H. U. Bergmeyer, Ed., pp. 163–172, Chemie, Weinheim, Germany, 3rd edition, 1984. View at Google Scholar
  21. K. G. M. M. Alberti, P. Zimmet, and J. Shaw, “The metabolic syndrome—a new worldwide definition,” The Lancet, vol. 366, no. 9491, pp. 1059–1062, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. R. H. Eckel, K. Alberti, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 375, no. 9710, pp. 181–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. D. H. Morris, K. Khunti, F. Achana et al., “Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis,” Diabetologia, vol. 56, no. 7, pp. 1489–1493, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. G. A. Nichols and E. J. Moler, “Diabetes incidence for all possible combinations of metabolic syndrome components,” Diabetes Research and Clinical Practice, vol. 90, no. 1, pp. 115–121, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Aekplakorn, P. Bunnag, M. Woodward et al., “A risk score for predicting incident diabetes in the Thai population,” Diabetes Care, vol. 29, no. 8, pp. 1872–1877, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. S.-J. Liu, Z.-R. Guo, X.-S. Hu et al., “Risks for type-2 diabetes associated with the metabolic syndrome and the interaction between impaired fasting glucose and other components of metabolic syndrome. the study from Jiangsu, China of 5 years follow-up,” Diabetes Research and Clinical Practice, vol. 81, no. 1, pp. 117–123, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Yakubovich and H. C. Gerstein, “Is regression to normoglycaemia clinically important?” The Lancet, vol. 379, no. 9833, pp. 2216–2218, 2012. View at Publisher · View at Google Scholar · View at Scopus